安图生物上半年营收、净利双降

Core Insights - Antu Biology (603658) reported a decline in both revenue and net profit for the first half of 2025 [1] Financial Performance - The company achieved operating revenue of 2.06 billion yuan, representing a year-on-year decrease of 6.65% [1] - The net profit attributable to shareholders was 571 million yuan, reflecting a year-on-year decline of 7.83% [1]